Determination of cysteinyl leukotrienes in exhaled breath condensate: Method combining immunoseparation with LC–ESI-MS/MS
A rapid and precise method for the identification and quantification of cysteinyl leukotrienes (leukotriene C 4, leukotriene D 4 and leukotriene E 4), essential markers of bronchial asthma, in exhaled breath condensate was developed. The protocol consists of immunoaffinity separation and a detection...
Saved in:
Published in | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 879; no. 23; pp. 2220 - 2228 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
01.08.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A rapid and precise method for the identification and quantification of cysteinyl leukotrienes (leukotriene C
4, leukotriene D
4 and leukotriene E
4), essential markers of bronchial asthma, in exhaled breath condensate was developed. The protocol consists of immunoaffinity separation and a detection step, liquid chromatography combined with electrospray ionization tandem mass spectrometry (LC–ESI-MS/MS). In particular, the selected reaction monitoring mode was used for its extremely high degree of selectivity and the stable-isotope-dilution assay for its high precision of quantification. The developed method was characterized with a high precision (≤7.7%, determined as RSD), an acceptable accuracy (90.4–93.7%, determined as recovery), a low limit of detection (≤2
pg/ml EBC) and a low limit of quantification (≤10
pg/ml EBC). It was compared to other simple, clinically appropriate combinations of pre-treatment methods (solid phase extraction and lyophilization) with LC/MS. Finally, the method (a combination of immunoaffinity separation with LC–MS) was successfully tested in a clinical study where a significant difference was found in the concentration levels of cysteinyl leukotrienes between patients with occupational bronchial asthma and healthy subjects. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.jchromb.2011.06.004 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 |
ISSN: | 1570-0232 1873-376X 1873-376X |
DOI: | 10.1016/j.jchromb.2011.06.004 |